Helsinn and Kyowa Kirin Asia Pacific sign exclusive license and distribution agreement to strengthen their presence in Asia Pacific’s rare disease therapy area

    NEXT STORY
    Sterilization Equipment Market to Reach $23.73 Billion by 2027 With COVID-19 Impact, at a CAGR of 12.2% from 2020 – Meticulous Research® Analysis
    PREV STORY
    Tiziana Life Sciences to Host Investor Update Call on 2 December 2020 at 4:15 p.m. ET
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Beroni Group Included in List of Commercial Manufacturers and Laboratories Who Have Notified US FDA of Validated Serology Tests for COVID-19

    author_avatar
    NASDAQ Market News

    The Myriad myRisk® Hereditary Cancer Test Identifies 60 Percent More Deleterious Mutations in Patients with Endometrial Cancer

    SALT LAKE CITY, March 18, 2016 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a ...

    author_avatar
    NASDAQ Market News

    Cancer Immunotherapy Market – Growth, Trends, and Forecasts (2020 – 2025)

    author_avatar
    NASDAQ Market News